Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT00165256
PHASE2
Wide Excision Alone as Treatment for Ductal Carcinoma in Situ of The Breast
Sponsor: Dana-Farber Cancer Institute
View on ClinicalTrials.gov
Summary
The purpose of this study is to determine if wide excision (surgical removal) alone is adequate treatment for small, grade 1 or 2 ductal carcinoma in situ (DCIS) of the breast.
Official title: Wide Excision Alone for DCIS-Grades 1 and 2
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
157
Start Date
1995-05-15
Completion Date
2026-06-25
Last Updated
2026-06-29
Healthy Volunteers
No
Conditions
Interventions
OTHER
Observation
Wide excision of DCIS and a minimum of 1cm histologically negative margin of breast tissue
Locations (2)
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Massachusetts General Hospital
Boston, Massachusetts, United States